IRF4 and neoplasm: The interaction between BATF and interferon regulatory factor 4 (IRF4) can reduce the expression of TOX, promote the effector differentiation of the transcriptional and epigenetic landscape of exhausted T cells [187], thereby improving the anti-tumor response of engineered T cells [188].